Citi Analyst Andrew Baum M.D. says the weight loss market could reach double the current projections of $160 billion in peak ...

Bruce Steel, CFA, is a Co-Founder, Director, and Chief Executive Officer of Equillium, Inc. Prior to co-founding Equillium, Mr. Steel was the Founder and Managing Director of BioMed Ventures, the ...

Vinson Walden, CFA, is a Founder and Portfolio Manager at City Different Investments. Prior to that, Mr. Walden was Co-Founder and Co-Portfolio Manager of Thornburg Global Opportunities Fund from ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Please start with a broad view of your coverage, and the subsectors, cap sizes and names you follow. Dr. Baum: So, I run Citi’s global research franchise, but my direct coverage is U.S. and European ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

David Nierengarten, Ph.D., is Managing Director and Head of Healthcare Equity Research at Wedbush Securities. He mainly covers development-stage therapeutic companies. He began his career on the ...

Let’s start with a brief overview and history of the company. Mr. de Garidel: Abivax was created in 2013 in France. It was essentially the work of what is called the CNRS, researchers at CNRS, which ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Let’s start with a brief overview and history of the company. Mr. Do: BioVie was started by Jonathan Adams to develop a drug called terlipressin to treat ascites, which is end stage liver disease. I ...